Table 7 .
Autoantibody titres before and after liver transplantation in patients without recurrent autoimmune hepatitis
| Patient (OLT) | Pre-OLT titre | Post-OLT titre, maximum level* |
|---|---|---|
| 241 | NA | Negative |
| 105 | SMA=1:180 | Negative |
| 272 | Anti-LC1=1: 320, anti-SLA− | LC1=1:320, anti-SLA− |
| 202 | Negative | SMA=1:80, anti-SLA− |
| 197 | NA | Negative |
| 370 | SMA=1:160 | SMA=1:160, anti-SLA− |
| 93 | Anti-LKM=1:1280, anti-SLA− | Anti-LKM=1:1280, anti-LC1=1:640, anti-SLA− |
| 157 | SMA=1:160 | Negative |
| 251 | Anti-LKM=1:1280, anti-SLA− | Anti-LKM=1:160, anti-SLA− |
| 391 | SMA=1:640 | Anti-SLA=1:60, anti-SLA− |
*Mean frequency of screening: yearly.
OLT, orthotopic liver tranplantation; NA, not available; SMA, smooth muscle antibodies; SLA, soluble liver antigen; LKM, liver kidney microsome; LC1, liver cytosol type 1.